Annual Current Assets
$665.77 M
+$261.44 M+64.66%
31 March 2024
Summary:
Immunovant annual total current assets is currently $665.77 million, with the most recent change of +$261.44 million (+64.66%) on 31 March 2024. During the last 3 years, it has risen by +$256.76 million (+62.78%). IMVT annual current assets is now at all-time high.IMVT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$507.37 M
-$81.67 M-13.87%
30 September 2024
Summary:
Immunovant quarterly total current assets is currently $507.37 million, with the most recent change of -$81.67 million (-13.87%) on 30 September 2024. Over the past year, it has increased by +$216.19 million (+74.25%). IMVT quarterly current assets is now -28.62% below its all-time high of $710.78 million, reached on 31 December 2023.IMVT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.7% | +74.3% |
| 3 y3 years | +62.8% | -10.0% |
| 5 y5 years | +10000.0% | +10000.0% |
IMVT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.7% | -28.6% | +74.3% |
| 5 y | 5 years | at high | >+9999.0% | -28.6% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -28.6% | >+9999.0% |
Immunovant Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $507.37 M(-13.9%) |
| June 2024 | - | $589.05 M(-11.5%) |
| Mar 2024 | $595.00 K(-60.5%) | $665.77 M(-6.3%) |
| Dec 2023 | - | $710.78 M(+144.1%) |
| Sept 2023 | - | $291.18 M(-16.8%) |
| June 2023 | - | $350.01 M(-13.4%) |
| Mar 2023 | $1.50 M(-42.8%) | $404.33 M(-11.0%) |
| Dec 2022 | - | $454.42 M(+6.6%) |
| Sept 2022 | - | $426.09 M(-6.6%) |
| June 2022 | - | $456.30 M(-11.0%) |
| Mar 2022 | $2.63 M | $512.93 M(-5.1%) |
| Dec 2021 | - | $540.48 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $563.79 M(+46.5%) |
| June 2021 | - | $384.83 M(-5.9%) |
| Mar 2021 | $3.48 M(+1019.9%) | $409.01 M(-4.8%) |
| Dec 2020 | - | $429.43 M(-4.6%) |
| Sept 2020 | - | $450.27 M(+57.4%) |
| June 2020 | - | $286.12 M(+162.3%) |
| Mar 2020 | $311.00 K(+288.8%) | $109.08 M(-13.8%) |
| Dec 2019 | - | $126.57 M(+7081.3%) |
| Sept 2019 | - | $1.76 M(-15.0%) |
| June 2019 | - | $2.07 M(+1303.2%) |
| Mar 2019 | - | $147.80 K |
| Dec 2018 | $80.00 K | - |
FAQ
- What is Immunovant annual total current assets?
- What is the all time high annual current assets for Immunovant?
- What is Immunovant annual current assets year-on-year change?
- What is Immunovant quarterly total current assets?
- What is the all time high quarterly current assets for Immunovant?
- What is Immunovant quarterly current assets year-on-year change?
What is Immunovant annual total current assets?
The current annual current assets of IMVT is $665.77 M
What is the all time high annual current assets for Immunovant?
Immunovant all-time high annual total current assets is $665.77 M
What is Immunovant annual current assets year-on-year change?
Over the past year, IMVT annual total current assets has changed by +$261.44 M (+64.66%)
What is Immunovant quarterly total current assets?
The current quarterly current assets of IMVT is $507.37 M
What is the all time high quarterly current assets for Immunovant?
Immunovant all-time high quarterly total current assets is $710.78 M
What is Immunovant quarterly current assets year-on-year change?
Over the past year, IMVT quarterly total current assets has changed by +$216.19 M (+74.25%)